Seeking Alpha

Alnylam Pharmaceuticals, Inc. (ALNY)

  • beleggersclub | Send Message 11 Aug

    BUY $ALNY at Price: 107.30 Stop: 103.57, Loss: 3.5% Target T1: 122.32, Profit: 14.2%
      • Robert A. Desmond | Send Message 22 Jul

        {video} Stock Chart Analysis $VDSI 4DUST $ERY $ENZN $ALNY $EYES $GOOGL $CALM
          • Marty Chilberg | Send Message 27 Jun

            Analyst Notes 6/24/15: $SYY $DEG $ALNY $KITE $KITE, $ALNY
              • wazzaofwallst | Send Message 24 Jun

                Alnylam Pharmaceuticals is in a great financial position, take a look: $ALNY
                Reply (1)
                • matratra | Send Message 24 Jun
                  : nope when IBB or IXB are negative
                  • Stephen Simpson, CFA | Send Message 12 Jun

                    Alnylam's CC5 Data More Like A Long Foul Than A Home-Run Or Strikeout $ALNY
                      • Derek Lowe | Send Message 12 Jun

                        Alnylam Sues Dicerna $ALNY, $DRNA
                          • Mike Zaman | Send Message 11 Jun

                            Box Inc (BOX) Better-Than-Expected Numbers; Alnylam (ALNY) Legal Battle Vs Dicerna (DRNA) $BOX, $ALNY, $DRNA
                              • Rod Raynovich | Send Message 14 May

                                Hot Biotech Sector: Mid-Caps Have Both M&A And Pipeline Premiums $ALNY, $PBYI
                                  • William Meyers | Send Message 28 Apr

                                    Is Alnylam In 2020 Worth $9 Billion Now? $ALNY
                                      • Stephen Simpson, CFA | Send Message 23 Apr

                                        Alnylam Strengthens Its Clinical Case Once Again $ALNY
                                          Visit Seeking Alpha's
                                          ALNY vs. ETF Alternatives
                                          Company Description
                                          Alnylam Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States